Genes such as BRCA1, CHEK2, and IKBKE are significantly upregulated in tumor tissues and serve as prognostic risk factors for GBM patients, suggesting that these genes may promote the initiation and progression of GBM by promoting neoplastic cell multiplication and impeding programed cell death [27]. This evidence concerns the gene CHEK2 and glioblastoma.